Published On:June 6 2008
Story Viewed 2232 Times

IPCA to enter US market

Coimbatore: IPCA Laboratories Ltd has received approval from the US Food and Drugs Administration to manufacture propranolol hydrochloride tablets USP 10 mg, 20 mg, 40 mg, 60 mg and 80 mg for the US market. Total annual market for the tablets in the US was $ 24.1 million.


OUR OTHER PRODUCTS & SERVICES: Projects Database | Tenders Database | About Us | Contact Us | Terms of Use | Advertise with Us | Privacy Policy | Disclaimer | Feedback

This site is best viewed with a resolution of 1024x768 (or higher) and supports Microsoft Internet Explorer 4.0 (or higher)
Copyright © 2016-2026

Technology Partner - Pairscript Software